RankingsPricing
  1. JP-listed companies
  2. SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.
  3. Financials
  4. Stockholders' equity

SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.JP:2395

Market cap
¥78.5B
P/E ratio
22.1x
SummaryFinancialsHistoryOwnershipWorkforce
Period EndStockholders' equity (Million JPY)YoY (%)
Mar 31, 202540,086+17.34%
Mar 31, 202434,161+29.60%
Mar 31, 202326,359+33.65%
Mar 31, 202219,723+24.52%
Mar 31, 202115,839-3.32%
Mar 31, 202016,382-42.48%
Mar 31, 201928,478+8.63%
Mar 31, 201826,216+16.65%
Mar 31, 201722,473+36.41%
Mar 31, 201616,475+70.83%
Mar 31, 20159,644-8.29%
Mar 31, 201410,515

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)